Semin Respir Crit Care Med 2022; 43(06): 851-861
DOI: 10.1055/s-0042-1753474
Review Article

Evaluation and Management of Indeterminate Pulmonary Nodules on Chest Computed Tomography in Asymptomatic Subjects: The Principles of Nodule Guidelines

Ju G. Nam
1   Department of Radiology, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
,
Jin Mo Goo
1   Department of Radiology, Seoul National University Hospital and College of Medicine, Seoul, Republic of Korea
2   Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea
3   Cancer Research Institute, Seoul National University, Seoul, Republic of Korea
› Author Affiliations

Abstract

With the rapidly increasing number of chest computed tomography (CT) examinations, the question of how to manage lung nodules found in asymptomatic patients has become increasingly important. Several nodule management guidelines have been developed that can be applied to incidentally found lung nodules (the Fleischner Society guideline), nodules found during lung cancer screening (International Early Lung Cancer Action Program protocol [I-ELCAP] and Lung CT Screening Reporting and Data System [Lung-RADS]), or both (American College of Chest Physicians guideline [ACCP], British Thoracic Society guideline [BTS], and National Comprehensive Cancer Network guideline [NCCN]). As the radiologic nodule type (solid, part-solid, and pure ground glass) and size are significant predictors of a nodule's nature, most guidelines categorize nodules in terms of these characteristics. Various methods exist for measuring the size of nodules, and the method recommended in each guideline should be followed. The diameter can be manually measured as a single maximal diameter or as an average of two-dimensional diameters, and software can be used to obtain volumetric measurements. It is important to properly evaluate and measure nodules and familiarize ourselves with the relevant guidelines to appropriately utilize medical resources and minimize unnecessary radiation exposure to patients.



Publication History

Article published online:
08 July 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. What do you mean, a spot?: a qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest 2013; 143 (03) 672-677
  • 2 Horeweg N, van Rosmalen J, Heuvelmans MA. et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014; 15 (12) 1332-1341
  • 3 McWilliams A, Tammemagi MC, Mayo JR. et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013; 369 (10) 910-919
  • 4 Henschke CI, Yip R, Yankelevitz DF, Smith JP. International Early Lung Cancer Action Program Investigators*. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013; 158 (04) 246-252
  • 5 MacMahon H, Naidich DP, Goo JM. et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 2017; 284 (01) 228-243
  • 6 Henschke CI. International Early Lung Cancer Action Program: screening protocol. Accessed February 3, 2022 at: https://www.ielcap.org/sites/default/files/I-ELCAP-protocol.pdf
  • 7 Lung CT. Screening Reporting & Data System (Lung-RADS) 2019. Version 1.1. Accessed February 3, 2022 at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads
  • 8 Gould MK, Donington J, Lynch WR. et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, suppl): e93S-e120S
  • 9 Baldwin DR, Callister ME. Guideline Development Group. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 2015; 70 (08) 794-798
  • 10 NCCN guidelines: lung cancer screening. 2020. Version 1. Accessed February 3, 2022 at: https://www.nccn.org/patients/guidelines/content/PDF/lung_screening-patient.pdf
  • 11 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246 (03) 697-722
  • 12 Erasmus JJ, Connolly JE, McAdams HP, Roggli VL. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 2000; 20 (01) 43-58
  • 13 Gaerte SC, Meyer CA, Winer-Muram HT, Tarver RD, Conces Jr DJ. Fat-containing lesions of the chest. Radiographics 2002; 22 (Spec No): S61-S78
  • 14 Matsuguma H, Oki I, Nakahara R. et al. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2013; 95 (06) 1878-1884
  • 15 Yoo R-E, Goo JM, Hwang EJ. et al. Retrospective assessment of interobserver agreement and accuracy in classifications and measurements in subsolid nodules with solid components less than 8mm: which window setting is better?. Eur Radiol 2017; 27 (04) 1369-1376
  • 16 Krist AH, Davidson KW, Mangione CM. et al; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA 2021; 325 (10) 962-970
  • 17 Tammemägi MC, Katki HA, Hocking WG. et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368 (08) 728-736
  • 18 Tammemägi MC, Church TR, Hocking WG. et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014; 11 (12) e1001764
  • 19 Field JK, Duffy SW, Baldwin DR. et al. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol Assess 2016; 20 (40) 1-146
  • 20 Kakinuma R, Noguchi M, Ashizawa K. et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 2016; 11 (07) 1012-1028
  • 21 Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178 (05) 1053-1057
  • 22 Oh J-Y, Kwon S-Y, Yoon H-I. et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer 2007; 55 (01) 67-73
  • 23 Lee SM, Park CM, Goo JM. et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010; 255 (01) 242-251
  • 24 Fu F, Zhang Y, Wen Z. et al. Distinct prognostic factors in patients with stage I non–small cell lung cancer with radiologic part-solid or solid lesions. J Thorac Oncol 2019; 14 (12) 2133-2142
  • 25 Kakinuma R, Muramatsu Y, Kusumoto M. et al. Solitary pure ground-glass nodules 5 mm or smaller: frequency of growth. Radiology 2015; 276 (03) 873-882
  • 26 Cohen JG, Reymond E, Lederlin M. et al. Differentiating pre- and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in Caucasian patients. Eur J Radiol 2015; 84 (04) 738-744
  • 27 Travis WD, Asamura H, Bankier AA. et al; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2016; 11 (08) 1204-1223
  • 28 Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. ELCAP Group. Screening for lung cancer: the early lung cancer action approach. Lung Cancer 2002; 35 (02) 143-148
  • 29 Zwirewich CV, Vedal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991; 179 (02) 469-476
  • 30 Lee KS, Kim Y, Han J, Ko EJ, Park C-K, Primack SL. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997; 17 (06) 1345-1357
  • 31 Takashima S, Sone S, Li F. et al. Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: Reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol 2003; 180 (04) 955-964
  • 32 Devaraj A, van Ginneken B, Nair A, Baldwin D. Use of volumetry for lung nodule management: theory and practice. Radiology 2017; 284 (03) 630-644
  • 33 Ashraf H, de Hoop B, Shaker SB. et al. Lung nodule volumetry: segmentation algorithms within the same software package cannot be used interchangeably. Eur Radiol 2010; 20 (08) 1878-1885
  • 34 Zhao YR, van Ooijen PM, Dorrius MD. et al. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations. Acta Radiol 2014; 55 (06) 691-698
  • 35 Petrou M, Quint LE, Nan B, Baker LH. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology. AJR Am J Roentgenol 2007; 188 (02) 306-312
  • 36 Honda O, Johkoh T, Sumikawa H. et al. Pulmonary nodules: 3D volumetric measurement with multidetector CT–effect of intravenous contrast medium. Radiology 2007; 245 (03) 881-887
  • 37 Christe A, Brönnimann A, Vock P. Volumetric analysis of lung nodules in computed tomography (CT): comparison of two different segmentation algorithm softwares and two different reconstruction filters on automated volume calculation. Acta Radiol 2014; 55 (01) 54-61
  • 38 Cohen JG, Kim H, Park SB. et al. Comparison of the effects of model-based iterative reconstruction and filtered back projection algorithms on software measurements in pulmonary subsolid nodules. Eur Radiol 2017; 27 (08) 3266-3274
  • 39 Kim H, Park CM, Chae H-D, Lee SM, Goo JM. Impact of radiation dose and iterative reconstruction on pulmonary nodule measurements at chest CT: a phantom study. Diagn Interv Radiol 2015; 21 (06) 459-465
  • 40 Ohno Y, Yaguchi A, Okazaki T. et al. Comparative evaluation of newly developed model-based and commercially available hybrid-type iterative reconstruction methods and filter back projection method in terms of accuracy of computer-aided volumetry (CADv) for low-dose CT protocols in phantom study. Eur J Radiol 2016; 85 (08) 1375-1382
  • 41 van Riel SJ, Sánchez CI, Bankier AA. et al. Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management. Radiology 2015; 277 (03) 863-871
  • 42 Revel M-P, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 2004; 231 (02) 453-458
  • 43 Wormanns D, Kohl G, Klotz E. et al. Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol 2004; 14 (01) 86-92
  • 44 Gietema HA, Schaefer-Prokop CM, Mali WP, Groenewegen G, Prokop M. Pulmonary nodules: Interscan variability of semiautomated volume measurements with multisection CT– influence of inspiration level, nodule size, and segmentation performance. Radiology 2007; 245 (03) 888-894
  • 45 Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997; 157 (08) 849-855
  • 46 Xu Y, Lu L, LN e. et al. Application of radiomics in predicting the malignancy of pulmonary nodules in different sizes. AJR Am J Roentgenol 2019; 213 (06) 1213-1220
  • 47 Zhang R, Sun H, Chen B, Xu R, Li W. Developing of risk models for small solid and subsolid pulmonary nodules based on clinical and quantitative radiomics features. J Thorac Dis 2021; 13 (07) 4156-4168
  • 48 Massion PP, Antic S, Ather S. et al. Assessing the accuracy of a deep learning method to risk stratify indeterminate pulmonary nodules. Am J Respir Crit Care Med 2020; 202 (02) 241-249
  • 49 Venkadesh KV, Setio AAA, Schreuder A. et al. Deep learning for malignancy risk estimation of pulmonary nodules detected at low-dose screening CT. Radiology 2021; 300 (02) 438-447
  • 50 de Hoop B, van Ginneken B, Gietema H, Prokop M. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012; 265 (02) 611-616
  • 51 Ahn MI, Gleeson TG, Chan IH. et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010; 254 (03) 949-956
  • 52 Mets OM, Chung K, Scholten ET. et al. Incidental perifissural nodules on routine chest computed tomography: lung cancer or not?. Eur Radiol 2018; 28 (03) 1095-1101
  • 53 Godoy MCB. Conservative management of juxtapleural nodules at low-dose ct lung cancer screening: Is this prudent?. Radiology 2020; 297 (03) 719-720
  • 54 Schreuder A, van Ginneken B, Scholten ET. et al. Classification of CT pulmonary opacities as perifissural nodules: reader variability. Radiology 2018; 288 (03) 867-875
  • 55 Zhu Y, Yip R, You N, Henschke CI, Yankelevitz DF. Management of nodules attached to the costal pleura at low-dose CT screening for lung cancer. Radiology 2020; 297 (03) 710-718
  • 56 Goo JM. Juxtapleural (perifissural) nodules: does location mean a benign lesion?. Radiology 2018; 288 (03) 876-877
  • 57 Kobayashi Y, Fukui T, Ito S. et al. How long should small lung lesions of ground-glass opacity be followed?. J Thorac Oncol 2013; 8 (03) 309-314
  • 58 Hiramatsu M, Inagaki T, Inagaki T. et al. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol 2008; 3 (11) 1245-1250
  • 59 Cho J, Kim ES, Kim SJ. et al. Long-term follow-up of small pulmonary ground-glass nodules stable for 3 years: implications of the proper follow-up period and risk factors for subsequent growth. J Thorac Oncol 2016; 11 (09) 1453-1459
  • 60 Lee HW, Jin K-N, Lee J-K. et al. Long-term follow-up of ground-glass nodules after 5 years of stability. J Thorac Oncol 2019; 14 (08) 1370-1377
  • 61 Lee JH, Lim WH, Hong JH. et al. Growth and clinical impact of 6-mm or larger subsolid nodules after 5 years of stability at chest CT. Radiology 2020; 295 (02) 448-455